This week: stories about Orbis Biosciences, KC Animal Health Corridor, an award for Truman Medical Center, exciting development news for UMKC and a study by Bayer Animal Health.
This week in Kansas City and Midwest biosciences news:
Precision Particle Fabrication technology of Orbis Biosciences is proving so versatile and accurate, that Orbis is now partnering with contractors from the Department of Defense to some of the top pharmaceutical and animal health companies on the market. How is such a small company making such huge strides this quickly?
Bob Marcusse, CEO of the Kansas City Area Development Council weighs in on how and why the KC Animal Health Corridor will give our Midwestern region an R&D/Investment advantage and all the economic spoils that comes with it for decades to come. He outlines six important factors…
With an eye toward revamping its image and then ultimately increasing output, the public relations and marketing team at Truman Medical Center (TMC) has exceeded expectations in attracting new Kansas City area moms to the hospital’s pre-natal and postpartum unit. Who is on the team making the big turnaround?
UMKC, area hospitals announced plans to develop a “bench-to-bedside” medical research center on Hospital Hill. The proposed Jackson County institute for translational research would be developed and operated in collaboration among UMKC, Children’s Mercy Hospitals and Clinics, Saint Luke’s Health System and the Kansas City Area Life Sciences Institute. Its primary fields of focus would be pediatric and geriatric medicine. How is it getting funded?
Bayer’s Animal Health Division published a surprising report about feline veterinary care. It found that despite owners spending a good percentage of their income on treats, toys and other non-vital pet-pleasing items, a majority of owners forego regular health checkups to keep their cats fit for the long term. They found some other pet owner behaviors that could use adjustments too…